| Literature DB >> 30404006 |
Roland Elling1, Elektra K Robinson2, Barbara Shapleigh2, Stephen C Liapis3, Sergio Covarrubias2, Sol Katzman4, Abigail F Groff3, Zhaozhao Jiang5, Shiuli Agarwal5, Mona Motwani5, Jennie Chan5, Shruti Sharma5, Elizabeth J Hennessy6, Garret A FitzGerald6, Michael T McManus7, John L Rinn8, Katherine A Fitzgerald5, Susan Carpenter9.
Abstract
An inducible gene expression program is a hallmark of the host inflammatory response. Recently, long intergenic non-coding RNAs (lincRNAs) have been shown to regulate the magnitude, duration, and resolution of these responses. Among these is lincRNA-Cox2, a dynamically regulated gene that broadly controls immune gene expression. To evaluate the in vivo functions of this lincRNA, we characterized multiple models of lincRNA-Cox2-deficient mice. LincRNA-Cox2-deficient macrophages and murine tissues had altered expression of inflammatory genes. Transcriptomic studies from various tissues revealed that deletion of the lincRNA-Cox2 locus also strongly impaired the basal and inducible expression of the neighboring gene prostaglandin-endoperoxide synthase (Ptgs2), encoding cyclooxygenase-2, a key enzyme in the prostaglandin biosynthesis pathway. By utilizing different genetic manipulations in vitro and in vivo, we found that lincRNA-Cox2 functions through an enhancer RNA mechanism to regulate Ptgs2. More importantly, lincRNA-Cox2 also functions in trans, independently of Ptgs2, to regulate critical innate immune genes in vivo. Published by Elsevier Inc.Entities:
Keywords: CRISPR/Cas9; CRISPRi; Ptgs2; inflammation; innate immunity; lincRNA-Cox2
Mesh:
Substances:
Year: 2018 PMID: 30404006 PMCID: PMC6291222 DOI: 10.1016/j.celrep.2018.10.027
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423